OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform

September 29, 2025

OptymEdge has hired Amy Del Medico as Senior Director, Project Delivery & Transformation, to lead the scale-up and global roll-out of ACUVERA — an integrated, AI-powered suite of technology solutions purpose-built for ophthalmology clinical trials. The platform will be soft-launched at next month’s American Academy of Ophthalmology (AAO) event in Orlando.

Del Medico brings more than 20 years of clinical trial experience across CROs and biopharma innovators. She spent 17 years at IQVIA, where she served as Director of the Center of Excellence for Ophthalmology, and most recently was Head of Clinical Operations at Vial.

Ophthalmology clinical trials are entering a new era of digital transformation, and OptymEdge is leading the industry in the adoption and integration of Visual Function Data Capture Solutions with advanced imaging, AI and analytics. Significantly, ACUVERA will seamlessly connect sites, sponsors, and CROs.  By standardizing workflows and enabling real-time access to imaging and clinical data, it ensures more consistent results, allowing faster decision making.

It’s a really exciting time for the business as we lead the digital transformation of ophthalmology clinical trials,” said Del Medico. “My focus will be on driving the global roll-out and adoption of the ACUVERA suite, which includes digital solutions for certification, data capture and ophthalmic image reading. Together, these new tools will enhance data quality and trial efficiency, and my goal is to ensure our delivery team can apply these new technologies and tools while bringing measurable impact to our customers and patients.” 

 

ACUVERA has been designed from the ground up as a bespoke solution. Unlike broad eClinical platforms, it combines deep therapeutic expertise with automation, RBQM insights, and endpoint-specific intelligence to deliver best-in-class Visual Function data capture, imaging, and certification. Del Medico added, “By unifying these critical workflows within a single, secure platform, sponsors and CROs can reduce operational complexity, improve endpoint quality, and accelerate study timelines. With many trials now looking to Asia and its large recruitment base, the key challenge is integrating processes across regions - particularly given the diversity of sites and evolving regulatory landscapes. ACUVERA will play a crucial role in harmonizing data, ensuring compliance, and enabling seamless collaboration across regions.”

 

-ENDS- 

Notes to editors:

For media inquiries, please contact:
Dana Roche
Director, Marketing & Communications, Emmes

droche@emmes.com